Pilot study of preoperative chemotherapy of XELOX+ Bevacizumab in patients with locally-advanced lower rectal cancer.
Phase of Trial: Phase II
Latest Information Update: 18 May 2016
At a glance
- Drugs Bevacizumab (Primary) ; Capecitabine; Paclitaxel
- Indications Rectal cancer
- Focus Adverse reactions
- 02 Feb 2012 Additional trial centre and investigator added as reported by University Hospital Medical Information Network - Japan.
- 23 Aug 2011 New trial record